TKPYY - Takeda Pharmaceutical Company Limited

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in JPY. All numbers in thousands
Revenue3/31/20173/31/20163/31/20153/31/2014
Total Revenue1,732,051,0001,807,378,0001,777,824,0001,691,685,000
Cost of Revenue557,676,000535,115,000520,213,000490,263,000
Gross Profit1,174,375,0001,272,263,0001,257,611,0001,201,422,000
Operating Expenses
Research Development311,625,000335,704,000367,741,000341,560,000
Selling General and Administrative615,867,000650,336,000612,489,000556,210,000
Non Recurring----
Others4,332,000155,000-2,087,0008,012,000
Total Operating Expenses1,601,608,0001,643,095,0001,621,577,0001,539,247,000
Operating Income or Loss130,443,000164,283,000156,247,000152,438,000
Income from Continuing Operations
Total Other Income/Expenses Net12,903,000-43,745,000-301,684,0006,412,000
Earnings Before Interest and Taxes130,443,000164,283,000156,247,000152,438,000
Interest Expense-7,560,000-5,271,000-5,796,000-4,888,000
Income Before Tax143,346,000120,538,000-145,437,000158,850,000
Income Tax Expense27,833,00037,059,000-2,403,00049,292,000
Minority Interest54,704,00062,511,00069,129,00069,896,000
Net Income From Continuing Ops115,513,00083,479,000-143,034,000109,558,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income114,940,00080,166,000-145,775,000106,658,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares114,940,00080,166,000-145,775,000106,658,000